Catalyst Event

Johnson & Johnson (JNJ) · Other

From Akros SCHK HK-Global Momentum Factor Index (ASHGMOM)

3/27/2026, 12:00:00 AM

OtherSentiment: Positive

The European Medicines Agency's (EMA) CHMP granted approval for a label update for Darzalex subcutaneous formulation for self-administration. Medium impact (~5%) expected from expanded market access. Expected.

Korean Translation

유럽 EMA CHMP, 다잘렉스 피하주사 제형의 자가 투여 라벨 업데이트 승인함. 시장 접근성 확대로 약 5%의 중간 수준 주가 영향이 예상됨. 예상됨.

Related Recent Events

View Full Timeline